[
    {
        "paperId": "03799b39d896d7094338b17e2ee837357c1730d1",
        "title": "Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis",
        "abstract": "Background and purpose:\u2002 There are other options open to patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) who are non\u2010responders to conventional treatment, including immunosuppressive and immunomodulatory agents (IA). The aim of this study was to assess whether the use of IA is able to increase the number of responders.",
        "year": 2011,
        "citation_count": 77,
        "relevance": 1,
        "explanation": "This paper explores alternative treatments for CIDP, which is relevant to the source paper's investigation of interferon beta-1a as a treatment for CIDP. However, it does not directly build upon or depend on the source paper's findings."
    }
]